Allarity Therapeutics ALLR
NASDAQ ALLR
$0.88 +0.00 (+0.48%)
As of: Oct 21, 2026 · 3:17 PM EDT

Allarity Therapeutics (ALLR) Work In Process (2022 - 2023)

Updated

Allarity Therapeutics (ALLR) posted Work In Process of $9.46 million for Q3 2023, down 2.6% from the prior quarter.

Analysis

Allarity Therapeutics (ALLR) Work In Process (2022 - 2023) Analysis & Trends

At the end of FY2022, Allarity Therapeutics' Work In Process came in at $9.55 million.

  • According to Business Quant data, Work In Process for the three prior quarters was $9.71 million (Q2 2023), $9.71 million (Q1 2023) and $9.55 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Allarity Therapeutics 14.00 Mn -54.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 9.46 Mn
Jun 30, 2023 9.71 Mn
Mar 31, 2023 9.71 Mn
Dec 31, 2022 9.55 Mn
API Access

Allarity Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=ALLR&period=max&api_key=YOUR_API_KEY